EUVIMEDEUVIMED entdecken
Systematische Übersicht

Parenteral Fosfomycin in Gastrointestinal Surgery: A Systematic Review

Siv Fonnes, Masja Klindt Fonnes, Barbara Juliane Holzknecht, Jacob Rosenberg

Drug Research · 01.01.2024 · 74 (01) · 24-31

DOI: 10.1055/a-2195-3032 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Drug Research, erschienen am 01.01.2024. Verfasst von Siv Fonnes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Perioperative Optimisation, Department of Surgery, Herlev Hospital, University of Copenhagen, Herlev, Denmark. Hauptthemen laut MEDLINE: Digestive System Surgical Procedures, Fosfomycin, Surgical Wound Infection. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To investigate if perioperative parenteral administration of fosfomycin given before or during gastrointestinal surgery could protect against postoperative infectious complications and characterise the administration of fosfomycin and its harms.

Methods

This systematic review included original studies on gastrointestinal surgery where parental administration of fosfomycin was given before or during surgery to≥5 patients. We searched three databases on March 24 2023 and registered the protocol before data extraction (CRD42020201268). Risk of bias was assessed with Cochrane Handbook risk of bias assessment tool or the Newcastle-Ottawa Scale. A narrative description was undertaken. For infectious complications, results from emergency and elective surgery were presented separately.

Results

We included 15 unique studies, reporting on 1,029 patients that received fosfomycin before or during gastrointestinal surgery. Almost half of the studies were conducted in the 1980s to early 1990s, and typically a dose of 4 g fosfomycin was given before surgery co-administered with metronidazole and often repeated postoperatively. The risk of bias across studies was moderate to high. The rates of infectious complications were low after fosfomycin; the surgical site infection rate was 0–1% in emergency surgery and 0–10% in elective surgery. If reported, harms were few and mild and typically related to the gastrointestinal system.

Conclusion

There were few postoperative infectious complications after perioperative parenteral administration of one or more doses of 4 g fosfomycin supplemented with metronidazole in various gastrointestinal procedures. Fosfomycin was associated with few and mild harms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Digestive System Surgical ProceduresFosfomycinSurgical Wound InfectionHumansMetronidazole

Substanzen

FosfomycinMetronidazole

Autor:innen und Institutionen

  • Centre for Perioperative Optimisation, Department of Surgery, Herlev Hospital, University of Copenhagen, Herlev, Denmark.
  • Department of Clinical Microbiology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen N, Denmark.

Zitieren

APA

Fonnes, S., Fonnes, M. K., Holzknecht, B. J., & Rosenberg, J. (2024). Parenteral Fosfomycin in Gastrointestinal Surgery: A Systematic Review. Drug Research, 74(01), 24-31. https://doi.org/10.1055/a-2195-3032

Vancouver

Fonnes S, Fonnes MK, Holzknecht BJ, Rosenberg J. Parenteral Fosfomycin in Gastrointestinal Surgery: A Systematic Review. Drug Research. 2024;74(01):24-31. doi:10.1055/a-2195-3032

BibTeX
@article{Fonnes2024,
  author = {Fonnes, Siv and Fonnes, Masja Klindt and Holzknecht, Barbara Juliane and Rosenberg, Jacob},
  title = {Parenteral Fosfomycin in Gastrointestinal Surgery: A Systematic Review},
  journal = {Drug Research},
  year = {2024},
  volume = {74},
  number = {01},
  pages = {24--31},
  doi = {10.1055/a-2195-3032}
}
Kostenlos starten →